Christoffer Clemmensen

51PUBLICATIONS
215CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer geneticsEvolutionary impacts of climate changeMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Sep 16, 2026
Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats.

|Jun 01, 2026
Novel Long-Acting Ghrelin Analogue PEP-064 Restores Energy Balance in C26 and Lewis Lung Carcinoma-Induced cachexia in Mice.

|May 13, 2026
The evolving landscape of obesity pharmacotherapy.

|Apr 03, 2026
Sex-specific metabolic responses to glucagon receptor agonism and modulation of the FGF21-glucagon axis in female mice.

Christoffer Merrild, Valdemar Brimnes Ingemann Johansen, Christoffer Clemmensen

|Nov 29, 2025
The NMDA Receptor Antagonist Memantine Modulates Aging and Stress Resilience.

Vaida Juozaityte, Chiara Pregnolato, Steffen Abay-Nørgaard

|Nov 24, 2025
LEAP2 as a therapeutic target in obesity and cardiometabolic disorders.

Stephanie K Holm, Valdemar Brimnes Ingemann Johansen, Christoffer Clemmensen

Pageof 9

Frequent Collaborators

11 joint publications

Jens Lund

7 joint publications

Pablo Ranea-Robles

5 joint publications

Brian Finan

5 joint publications

Zachary Gerhart-Hines